As the India AI Impact Summit 2026 enters its final stretch in the national capital, five days of structured dialogue, collaboration and cross sector innovation have reinforced India’s growing leadership in artificial intelligence. Blockchain For Impact (BFI) has played a central role in the healthcare track, curating startup showcases and high-level discussions at their pavilion that reflect the accelerating momentum within India’s AI-driven biomedical ecosystem.
Sandeep Nailwal, Founder, Blockchain For Impact, said, “AI in healthcare is not about replacing doctors, it is about strengthening them. Doctors are open to technology, provided it is backed by evidence, validated rigorously, and built for real world use. Our collective focus must be on creating AI systems that are trustworthy, transparent and outcome driven.”
A key highlight was the startup pitching session hosted by BFI-BIOME, where ten AI powered healthcare startups presented solutions across diagnostics, oncology, newborn care and preventive screening. The showcase reflected a strong shift toward technologies built for deployment in clinical and community settings. Among the top performing startups were Medmarvel, represented by Rupal Mehta, and AICA Health, represented by Manisha, both of whom stood out for the strength and clarity of their AI led healthcare solutions.
Plotnew Bio Innovations introduced an AI enabled, pen style saliva diagnostic device designed to monitor tuberculosis drug adherence and detect early liver toxicity. AiSteth presented AI powered smart stethoscope capable of screening and predicting cardio-respiratory disorders at primary health centres. Diagno+, developed at IHFC, IIT Delhi, demonstrated an AI based clinical decision support platform aimed at reducing diagnostic delays in brain tumor detection.
Spartis Tech showcased software that converts routine X-rays into CT-like 3D bone mineral density heatmaps for improved osteoporosis screening. Ayukriyam Innovations highlighted its automated microscopy platform with AI assisted diagnosis for tuberculosis and cervical cancer. Transcript Life Sciences presented its machine learning driven approach to accelerating cancer combination therapies.
Adsys Medtech demonstrated a compact, point-of-care CBC diagnostic device designed for decentralized healthcare settings. Astraeus Innovus presented OncoALERT, an AI and nanotechnology-powered oral cancer screening solution enabling rapid and accessible detection. Nemocare Wellness showcased Nemocare Raksha, an AI-enabled wearable platform for early identification of distress in newborns.
The day also had two focused panel discussions examining structural enablers of healthcare innovation. The session titled “Transforming Private Universities into AI Innovation Hubs: A Centre of Excellence Approach” emphasized embedding innovation within academic frameworks. Panelists discussed the need to build Centres of Excellence that translate research into scalable healthcare solutions, strengthen industry partnerships and prepare future ready leaders by making innovation a structured and measurable academic discipline.
The second session, “Investing in Biotech & MedTech: Risk, Regulation & Global Opportunity,” addressed the evolving investment landscape in biomedical innovation. The discussion emphasized that successful ventures must demonstrate regulatory readiness, measurable clinical impact and scalability across global markets.
As the India AI Impact Summit 2026 progresses into its final sessions, a clear message is emerging: India’s AI healthcare ecosystem is moving from early experimentation toward structured, disciplined execution. Through coordinated academic reform, strategic capital deployment and scalable innovation platforms, BFI and its partners are strengthening the pathways required to translate AI-driven breakthroughs into accessible and sustainable healthcare outcomes across India and beyond.